Authors:
Martinez-Gonzalez, J
Alfon, J
Berrozpe, M
Badimon, L
Citation: J. Martinez-gonzalez et al., HMG-CoA reductase inhibitors reduce vascular monocyte chemotactic protein-1 expression in early lesions from hypercholesterolemic swine independentlyof their effect on plasma cholesterol levels, ATHEROSCLER, 159(1), 2001, pp. 27-33
Authors:
Martinez-Gonzalez, J
Berrozpe, M
Varela, O
Badimon, L
Citation: J. Martinez-gonzalez et al., Heterogeneity of smooth muscle cells in advanced human atherosclerotic plaques: intimal smooth muscle cells expressing a fibroblast surface protein are highly activated by platelet-released products, EUR J CL IN, 31(11), 2001, pp. 939-949
Citation: T. Royo et al., Effect of gemfibrozil on peripheral atherosclerosis and platelet activation in a pig model of hyperlipidemia, EUR J CL IN, 30(10), 2000, pp. 843-852
Authors:
Alfon, J
Guasch, JF
Berrozpe, M
Badimon, L
Citation: J. Alfon et al., Nitric oxide synthase II (NOS II) gene expression correlates with atherosclerotic intimal thickening. Preventive effects of HMG-CoA reductase inhibitors, ATHEROSCLER, 145(2), 1999, pp. 325-331
Authors:
Badimon, JJ
Lettino, M
Toschi, V
Fuster, V
Berrozpe, M
Chesebro, JH
Badimon, L
Citation: Jj. Badimon et al., Local inhibition of tissue factor reduces the thrombogenicity of disruptedhuman atherosclerotic plaques - Effects of tissue factor pathway inhibitoron plaque thrombogenicity under flow conditions, CIRCULATION, 99(14), 1999, pp. 1780-1787